Wan Mengxia, He Ji, Huo Junyan, Sun Can, Fu Yu, Fan Dongsheng
Department of Neurology, Peking University Third Hospital, Beijing 100191, China.
Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing 100191, China.
Brain Sci. 2023 Jan 1;13(1):85. doi: 10.3390/brainsci13010085.
GGC repeat expansions in the 5' untranslated region (5'UTR) of the Notch Homolog 2 N-terminal-like C gene () have been reported to be the genetic cause of neuronal intranuclear inclusion disease (NIID). However, whether they exist in other neurodegenerative disorders remains unclear. To determine whether there is a medium-length amplification of in patients with amyotrophic lateral sclerosis (ALS), we screened 476 ALS patients and 210 healthy controls for the presence of a GGC repeat expansion in by using repeat-primed polymerase chain reaction (RP-PCR) and fragment analysis. The repeat number in ALS patients was 16.11 ± 5.7 (range 7-46), whereas the repeat number in control subjects was 16.19 ± 3.79 (range 10-29). An intermediate-length GGC repeat expansion was observed in two ALS patients (numbers of repeats: 45, 46; normal repeat number ≤ 40) but not in the control group. The results suggested that the intermediate GGC repeat expansion was associated with Chinese ALS patients, and further functional studies for intermediate-length variation are required to identify the mechanism.
据报道,Notch同源物2 N端样C基因()5'非翻译区(5'UTR)中的GGC重复扩增是神经元核内包涵体病(NIID)的遗传病因。然而,它们是否存在于其他神经退行性疾病中仍不清楚。为了确定肌萎缩侧索硬化症(ALS)患者中是否存在的中等长度扩增,我们通过重复引物聚合酶链反应(RP-PCR)和片段分析,对476例ALS患者和210名健康对照进行了筛查,以检测中是否存在GGC重复扩增。ALS患者的重复数为16.11±5.7(范围7-46),而对照受试者的重复数为16.19±3.79(范围10-29)。在两名ALS患者中观察到中等长度的GGC重复扩增(重复数:45、46;正常重复数≤40),但在对照组中未观察到。结果表明,中等长度的GGC重复扩增与中国ALS患者有关,需要进一步对中等长度变异进行功能研究以确定其机制。